**Core Concept**
Pulmonary fibrosis is a type of interstitial lung disease characterized by the accumulation of scar tissue in the lungs, leading to impaired gas exchange and respiratory function. This condition can result from various causes, including exposure to harmful substances, autoimmune disorders, and certain medications.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of pulmonary fibrosis, which involves the activation of fibroblasts and the deposition of extracellular matrix proteins, such as collagen. This process is often triggered by injury to the lung tissue, which can be caused by exposure to substances like asbestos. The activation of transforming growth factor-beta (TGF-β) plays a crucial role in the fibrotic process by promoting the differentiation of fibroblasts into myofibroblasts and the production of extracellular matrix proteins.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not directly relate to the pathophysiology of pulmonary fibrosis. While certain autoimmune disorders can cause pulmonary fibrosis, this option is too broad and does not specifically address the underlying mechanisms of the disease.
* **Option C:** This option is incorrect because it refers to a different type of lung disease. Chronic bronchitis is a type of obstructive lung disease characterized by chronic inflammation of the bronchial tubes, whereas pulmonary fibrosis is a type of interstitial lung disease.

**Clinical Pearl / High-Yield Fact**
One key point to remember is that the use of certain medications, such as amiodarone and bleomycin, can increase the risk of developing pulmonary fibrosis. This is an important consideration for clinicians when prescribing these medications, particularly in patients with pre-existing lung disease.

**Correct Answer:**
B. Asbestos exposure is a well-established cause of pulmonary fibrosis, particularly pleural plaques and asbestosis.